Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

[Epidemiology of multiple sclerosis in the Primosky Krai and Far East regions.]
Application of serum natalizumab levels during plasma exchange in MS patients with progressive multifocal leukoencephalopathy.
Secret talk between adipose tissue and central nervous system via secreted factors-an emerging frontier in the neurodegenerative research.
Guidelines for the use of intravenous immunoglobulin in the treatment of neurologic diseases.
The influence of ethnicity on the characteristics of multiple sclerosis: A local population study between Persians and Arabs.
Alpha4-integrin antagonism--an effective approach for the treatment of inflammatory diseases?
Pilates based core stability training in ambulant individuals with multiple sclerosis: Protocol for a multi-centre randomised controlled trial.
Physiopathology of symptoms and signs in multiple sclerosis.
3D models of human ERα and ERβ complexed with coumestrol.
Memory rehabilitation for people with multiple sclerosis.
Involvement of oxidative stress on the impairment of energy metabolism induced by A beta peptides on PC12 cells: protection by antioxidants.
Treatment of relapsing-remitting multiple sclerosis with high-dose cyclophosphamide induction followed by glatiramer acetate maintenance.
Two Years Follow up of Domain Specific Cognitive Training in Relapsing Remitting Multiple Sclerosis: A Randomized Clinical Trial.
Parent-of-origin effect in multiple sclerosis: observations in half-siblings.
Mechanism for p38α-mediated experimental autoimmune encephalomyelitis.
Differential glatiramer acetate treatment persistence in treatment-naive patients compared to patients previously treated with interferon.
UPDATE 2-FDA panel supports approval of Sanofi's MS drug Lemtrada
ONO-4641 Met Primary Endpoint of Phase II Study in Multiple Sclerosis Patients
Managing fatigue in patients with multiple sclerosis.
A Herpes Simplex Virus-Derived Replicative Vector Expressing LIF Limits Experimental Demyelinating Disease and Modulates Autoimmunity.
Non-stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll-like receptor 4 (TLR4).
Extracranial Venous abnormalities: A true pathological finding in patients with multiple sclerosis or an anatomical variant?
Association between soluble L-selectin and anti-JCV antibodies in natalizumab-treated relapsing-remitting MS patients.
Serum pharmacokinetics and cerebrospinal fluid concentration analysis of the new IgG4 monoclonal antibody GNbAC1 to treat multiple sclerosis: a Phase 1 study.
Vitamin D status is associated with relapse rate in pediatric-onset multiple sclerosis.

Pages